Toxicity Screening After Single Dose of a Newly Developed Oral Heparin Derivative in Male Cynomolgus Monkeys |
Kim, Choong-Yong
(Non-Human Primate Team, Toxicology Division, Korea Institute of Toxicology, KRICT)
Kim, Sang-Kyoon (Department of Materials Science and Engineering, Gwangju Institute of Science and Technology) Woo, Young-Ah (Non-Human Primate Team, Toxicology Division, Korea Institute of Toxicology, KRICT) Jeong, Eun-Ju (Non-Human Primate Team, Toxicology Division, Korea Institute of Toxicology, KRICT) Han, Su-Cheol (Non-Human Primate Team, Toxicology Division, Korea Institute of Toxicology, KRICT) Heo, Jeong-Doo (Non-Human Primate Team, Toxicology Division, Korea Institute of Toxicology, KRICT) Park, Kui-Lea (National Institute of Toxicological Research) Byun, Young-Ro (College of Pharmacy, Seoul National University) |
1 | Gonze, M.D., Salartash, K., Sternbergh III, W.C., Baughman R.A., Leone-Bay, A. and Money, S.R. (2000). Orally administered unfractionated heparin with carrier agent is therapeutic for deep venous thrombosis. Circulation, 101, 2658-2661 DOI ScienceOn |
2 | Malkov, D., Wang, H., Dinh, S., Steven, D. and Gomez-Orellana, I. (2002). Pathway of oral absorption of heparin with sodium N-(8-(2 hydroxybenzoyl)amino) caprylate. Pharm. Res.. 19, 1180-1184 DOI ScienceOn |
3 | 김충용, 이현숙, 한수철, 허정두, 하창수, 권명상, 정문구 (2004). Cynomolgus monkey에 있어 혈액학 및 혈액생화학적 지표. 한국실험동물학회지, 20, 44-48 |
4 | Lee, Y.K., Kim, S.K., Lee, D.Y., Lee, S., Kim, C.Y., Shin, H.C. and Moon, H.T. (2006). Efficacy of orally active chemical conjugate of low molecular weight heparin and deoxycholic acid in rats, mice and monkeys. J. Control Release, 111, 290-298 DOI ScienceOn |
5 | Mark, D.G., Jeffrey, D.M. and Andrea, L.B. (1998). Orally administered heparin for preventing deep venous thrombosis. Am. J. Surg., 176, 176-178 |
6 | Menajovsky, L.B. (2005). Heparin-induced thrombocytopenia: clinical manifestations and management. Am. J. Med., 118(Suppl. 8A), 21S-30S |
7 | Aken, H.V., Bode, C.B., Darius, H., Diehm, C., Encke, A., Gulba, D.C., Haas, S., Haccke, W., Puhl, W., Quante, M., Riess, H., Scharf, R., Schellong, S., Schror, K., Schulte, K.-L. and Tebbe, U. (2001). Anticoagulation: The present and future. Clin. Appl. Thrombo. Hemost., 7, 195-204 DOI ScienceOn |
8 | 정영미 (2006). 항응고제치료에 사용되는 약물. 병원약사회지, 23, 5-11 |
9 | Wolford, S.T., Schroer, R.A., Gohs, F.X., Gallo, P.P., Brodeck, M., Falk, H.B. and Ruhren, R.R. (1986). Reference range data base for serum chemistry and hematology values in laboratory animals. J. Toxicol. Environ. Heal., 18, 161- 188 DOI ScienceOn |
10 | Strandness, D.E. Jr. (2001). Anticoagulant therapy: Current status and shortcomings. Seminars in Interventional Radiology, 18, 113-118 |
11 | Cines, D.B., Rauova, L., Arepally, G., Reilly, M.P., McKenzie, S.E., Sachais, B.S. and Poncz, M. (2007). Heparininduced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly. J. Clin. Apher., 22, 31-36 DOI ScienceOn |
12 | Kim, S.K., Vaishali, B., Lee, E., Lee, S., Lee, Y.K., Kumar, T.S., Moon, H.T. and Byun, Y. (2006). Oral delivery of chemical conjugates of heparin and deoxycholic acid in aqueous formulation. Thromb. Res., 117, 419-427 DOI ScienceOn |
13 | Lee, Y., Moon, H.T. and Byun, Y. (1998). Preparation of slightly hydrophobic heparin derivatives which can be used for solvent casting in polymeric formulation. Thromb. Res., 92, 149-156 DOI ScienceOn |
14 | Ginsberg, J.S. (1999). Thromboembolism and pregnancy. Thromb. Haemost., 82, 620-625 DOI |
15 | Hull, R., Delmore, T., Carter, C., Hirsh, J., Genton, E., Gent, M., Turpie, G. and McLaughlin, D. (1982). Adjusted subcutaneous heparin versus warfarin sodium in the longterm treatment of venous thrombosis. N. Engl. J. Med., 306, 189-194 DOI ScienceOn |
16 | Lee, Y., Nam, J.H., Shin, H.C. and Byun, Y. (2001). Conjugation of low-molecular-weight heparin and deoxycholic acid for the development of a new oral anticoagulant agent. Circulation, 104, 3116-3120 DOI ScienceOn |
17 | Hirsh, J. and Fuster, V. (1994). Guide to anticoagulant therapy, Part 1: heparin. Circulation, 89, 14449-1468 |
18 | Hirsh, J. (2003). Current anticoagulant therapy-unmet clinical needs. Throm. Res., 109, S1-S8 DOI ScienceOn |
19 | Alpert, J.S. and Dalen, J.E. (1994). Epidemiology and natural history of venous thromboembolism. Prog. Cardiovasc. Dis., 36, 417-422 DOI ScienceOn |